期刊文献+

瑞他莫林——一种新的外用抗菌药

原文传递
导出
摘要 皮肤与软组织感染是皮肤科常见病,而细菌对常用的外用抗菌药物的耐药性正在全球范围内增加,这些药物包括莫匹罗星与夫西地酸。如金黄色葡萄球菌对莫匹罗星的耐药率在拉丁美洲为1.3%,欧洲为8.7%,美国为32.5%;凝血酶阴性的葡萄球菌对莫匹罗星的耐药率欧洲为12.7%,
作者 李奇 徐文严
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2012年第2期147-149,共3页 Chinese Journal of Dermatology
  • 相关文献

参考文献17

  • 1Jones RN,Fritsche TR,Sader HS,et al.Activity of retapamulin (SB-275833),a novel pleuromulin against selected gram-positive cocci.Antimicrob Agents Chemother,2006,50(7):2583-2586.
  • 2Shah M,Mohanraj M.High levels of fusidic acid-resistant Staphylococcus aureus in dermatology patients.Br J Dermatol,2003,148(5):1018-1020.
  • 3Pankuch GA,Lin G,Hoellman DB,et al.Activity of retapamulin against Streptococcus pyogenes and Staphylococcus aureus,evaluated by agar dilution,microdilution,E-test,and disk diffusion methodologies.Antimicrob Agents Chemother,2006,50 (5):1727-1730.
  • 4Scangarella-Oman N,Shawar RM,Bouchillon S,et al.Microbiological profile of a new topical antibacterial:retapamulin ointment 1%.Expert Rev Anti Infect Ther,2009,7(3):269-279.
  • 5Traczewski MM,Brown SD.Proposed MIC and disk microbiological cutoffs and spectrum of activity of retapamulin,a novel topical antimicrobial agent.Antimicrob Agents Chemother,2008,52(11):3863-3867.
  • 6Ross JE,Jones RN.Quality control guidelines for susceptibility testing of retapamulin (SB-275833) by reference and standardized methods.J Clin Microbiol,2005,43(12):6212-6213.
  • 7McConeghy KW,Mikolich DJ,LaPlante KL.Agents for the decolonization of methicillin-resistant Staphylococcus aureus.Pharmacotherapy,2009,29(3):263-280.
  • 8Champney WS,Rodgers WK.Retapamulin inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.Antimicrob Agents Chemother,2007,51 (9):3385-3387.
  • 9Abramovits W,Gupta A,Gover M.Altabax (retapamulin ointment).1%.Skinmed,2007,6(5):239-240.
  • 10Kosowska-Shik K,Clark C,Credito K,et al.Single-and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes.Antimicrob Agents Chemother,2006,50(2):765-769.

二级参考文献3

  • 1Odou M F, Miler C, Calvet L, et al. In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections. J Antimicrob Chemother,2007,59:646.
  • 2Free A, Both E, Dalessandro M, et al. Retapamulin ointment twice daily for 5 days vs oral cephalexin twice daily for 10 days for empiric treatment of secondarily infected traumatic lesions of the skin. Skinmed, 2006,5 : 224.
  • 3Parish L C, Jorizzo J L, Breton J J, et al. Topical retapamulin ointment ( 1% wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in lhe treatment of secondarily infected dermatitis: resets of a randomized controlled trial. J Am Aead Dermatol,2006,55:1003.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部